Primary Site >> Biliary tract Cancer
Gene >> HCCS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. PMID: 2449824 |
Ref: Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience. PMID: 8209017 |
Ref: Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. PMID: 7545644 Ref: Significance of endothelium in the fine-needle aspiration biopsy diagnosis of hepatocellular carcinoma. PMID: 7621715 |
Ref: The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. PMID: 8878022 Ref: Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. PMID: 8908545 |
Ref: Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. PMID: 9049204 |
Ref: Nonsurgical therapies for hepatocellular and cholangiocellular carcinoma. PMID: 10414182 |
Ref: A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas. PMID: 11244331 Ref: cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. PMID: 11583969 Ref: Hepatocellular carcinoma: an update. PMID: 11783914 |
Ref: Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. PMID: 12000734 |
Ref: Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. PMID: 12563151 Ref: Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. PMID: 14508391 |
Ref: A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. PMID: 15221469 Ref: Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma. PMID: 15448317 |
Ref: Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. PMID: 15722574 Ref: Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. PMID: 16204727 Ref: [A long-term survival of the patient with hepatocellular carcinoma and advanced portal vein and bile duct tumor thrombosis successfully treated with multimodal treatments]. PMID: 16315947 |
Ref: Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? PMID: 16565954 Ref: The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. PMID: 16680226 Ref: [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany]. PMID: 16850381 Ref: The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. PMID: 18376797 |
Ref: MR imaging of hepatocellular carcinomas with biliary tumor thrombi. PMID: 17151901 Ref: A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. PMID: 17553067 Ref: Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. PMID: 17640714 Ref: Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. PMID: 17729001 |
Ref: Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. PMID: 18393293 Ref: A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. PMID: 18997056 |
Ref: Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. PMID: 18316169 Ref: Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. PMID: 19212669 Ref: [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts]. PMID: 19627020 |
Ref: The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. PMID: 19350315 Ref: Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. PMID: 19760416 Ref: Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas. PMID: 20471664 Ref: Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. PMID: 20477996 Ref: Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet. PMID: 20842700 |
Ref: Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree. PMID: 21281432 Ref: Hepatocellular carcinoma with bile duct tumor thrombus: dynamic computed tomography findings and histopathologic correlation. PMID: 21412088 Ref: Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma. PMID: 21528069 Ref: Novel therapeutic strategies for targeting liver cancer stem cells. PMID: 21552419 Ref: Era of diagnostic and interventional ultrasound. PMID: 21666820 Ref: Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. PMID: 21762411 Ref: What we learned from difficult hepatectomies in patients with advanced hepatic malignancy. PMID: 26421042 |
Ref: Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. PMID: 22119409 Ref: Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma. PMID: 22194045 Ref: Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. PMID: 22425613 |
Ref: Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. PMID: 22829097 Ref: Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms. PMID: 23079207 Ref: Constitutive Notch2 signaling induces hepatic tumors in mice. PMID: 23175466 Ref: Improving detection and treatment of liver cancer. PMID: 24191431 Ref: Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. PMID: 24349281 Ref: [Three cases of recurrent hepatocellular carcinoma treated with laparoscopic hepatectomy after oral administration of sorafenib]. PMID: 24393884 |
Ref: Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound. PMID: 24118042 Ref: Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis. PMID: 24530461 Ref: Tricellulin expression and its prognostic significance in primary liver carcinomas. PMID: 24652413 Ref: Histopathology of hepatocellular carcinoma. PMID: 25473149 Ref: Clinical significance of increased expression of Nijmegen breakage syndrome gene (NBS1) in human primary liver cancer. PMID: 26202506 |
Ref: Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. PMID: 25353287 Ref: Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging. PMID: 25447030 Ref: Modulation of Notch signaling as a therapeutic approach for liver cancer. PMID: 25537772 Ref: Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma. PMID: 25579172 Ref: Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. PMID: 25636086 Ref: Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver. PMID: 26300935 Ref: The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma. PMID: 26386477 Ref: Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging. PMID: 26488875 Ref: Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. PMID: 26779444 |
Ref: Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. PMID: 26373763 Ref: Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis. PMID: 26634931 Ref: Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study. PMID: 26668057 Ref: Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity. PMID: 26672766 Ref: BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas. PMID: 26735860 Ref: Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma. PMID: 26752112 Ref: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion. PMID: 27032374 Ref: Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging. PMID: 27077381 Ref: Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation. PMID: 27320551 Ref: LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations. PMID: 27486793 |
Ref: Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT. PMID: 27797675 Ref: Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. PMID: 28043904 Ref: Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. PMID: 28078380 Ref: Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI. PMID: 28124105 Ref: IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing. PMID: 28403884 Ref: Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology. PMID: 28449169 Ref: Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI. PMID: 28500365 Ref: Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. PMID: 28562394 Ref: Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum. PMID: 28624005 Ref: Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. PMID: 29130106 |
Ref: Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. PMID: 29335868 Ref: Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. PMID: 29378174 Ref: Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance. PMID: 29470629 Ref: Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. PMID: 29675659 Ref: Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size. PMID: 29791202 Ref: Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients. PMID: 29879746 Ref: Characteristics of contrast-enhanced ultrasound in distinguishing small ( PMID: 30313099 |